1.Lewis, DA, Campbell, MS, Terry, RD, et al. Laminar and regional distribution of neurofibrillary tangles and neuritic plaques in Alzheimer’s disease: a quantitative study of visual and auditory cortices. J Neurosci 1987; 7: 1799–1808.
2.Pearson, RCA, Esiri, MM, Hioms, RW, et al. Anatomical correlates of the distribution of pathological changes in the neocortex in Alzheimer’s disease. Proc Natl Acad Sci USA 1985; 82: 4531–4534.
3.Rogers, J, Morrison, JH. Quantitative morphology and regional laminar distributions of senile plaques in Alzheimer’s disease. J Neurosci 1985; 5: 2801–2808.
4.Conti, F, Rustioni, A, Petrusz, P, et al. Glutamat-positive neurons in the somatic sensory cortex of rats and monkeys. J Neurosci 1987; 7: 1887–1901.
5.Storm-Mathisen, J, Leknes, AK, Bose, AT, et al. First visualization of glutamate and GABA in neurones by immunocytochemistry. Nature 1983; 301: 517–520.
6.Rustioni, A, Cuenod, M. Selective retrograde transport of D-aspartate in spinal interneurons and cortical neurons of rats. Brain Res 1982; 236: 143–155.
7.McGeer, PL, Eccles, JC, McGeer, EG. Molecular Neurobiology of the Mammalian Brain. New York; Raven Press, 1987: 180–186.
8.Donaghue, JP, Wenthold, RJ, Altschuler, RA. Localization of glutaminase-like and aspartate aminotransferase-like immunoreactivi-ties in neurons of cerebral cortex. J Neurosci 1985; 5: 2597–2608.
9.Kaneko, T, Mizuno, N. Immunohistochemical study of glutaminasecontaining neurons in the cerebral cortex and thalamus of the rat. J Comp Neurol 1988; 267: 599–602.
10.Akiyama, H, McGeer, PL, Itagaki, S, et al. Loss of glutaminase-positive cortical neurons in Alzheimer’s disease. Neurocheni Res 1989; 14: 453–458.
11.Altshuler, RA, Monaghan, DT, Haser, WG, et al. Imniunocytochemical localization of glutaminase-like and aspartate aminotransferase-like immunoreactivities in the rat and guinea pig hippocampus. Brain Res 1985; 330: 225–233.
12.Cross, AJ, Crow, TJ, Dawson, JM, et al. Subcellular pathology of human neurodegenerative disorders: Alzheimer-type dementia and Huntington’s disease. J Neurochem 1986; 47: 882–889.
13.McGeer, PL, Kamo, H, Harrop, R, et al. Comparison of PET, MRI and CT with pathology in a proven case of Alzheimer’s disease. Neurology 1986; 36: 1569–1574.
14.Kaneko, T, Urade, Y, Watanabe, Yet al. Production, characterization and immunohistochemical application of monoclonal antibodies to glutaminase purified from rat brain. J Neurosci 1987; 7: 302–309.
15.McGeer, EG, Singh, EA, McGeer, PL. —Glutamyl transferase: normal cortical levels in Alzheimer’s disease. Alz Dis Assoc Disord 1987; 1: 50–63.
16.Lowry, OH, Rosebrough, NJ, Farr, AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275.
17.McGeer, PL, Kamo, H, Harrop, R, et al. Positron emission tomography in patients with clinically diagnosed Alzheimer’s disease. Can Med Assoc J 1986; 134: 597–607.
18.Akiyama, H, Harrop, R, McGeer, PL, et al. Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer’s disease. Neurology 1989; 39: 541–548.
19.McGeer, PL. Brain imaging in Alzheimer’s disease. Br Med Bull 1986; 42: 24–28.
20.McGeer, PL, Itagaki, S, Tago, H, et al. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility protein HLA–DR. Neurosci Lett 1087; 79: 195–200.
21.Itagaki, S, McGeer, PL, Akiyama, H. Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer’s disease brain tissue. Neurosci Lett 1988; 91: 259–264.
22.Procter, AW, Lowe, SL, Palmer, AM, et al. Topographical distribution of neurochemical changes in Alzheimer’s disease. J Neurol Sci 1988; 84: 125–140.
23.Francis, FT, Bowen, DM. Tacrine, a drug with therapeutic potential for dementia: post-mortem biochemical evidence. Can J Neurol Sci (in press - this symposium).
24.McGeer, PL, McGeer, EG. Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson’s disease and Huntington’s chorea. J Neurochem 1976; 26: 65–76.